MIF -173G/C polymorphism is associated with NMO disease severity. Brill L, Vaknin-Dembinsky A, Zveik O, Haham N, et al. J Neuroimmunol 2020;339:577120.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brill L, Vaknin-Dembinsky A, Zveik O, Haham N, et al. MIF -173G/C polymorphism is associated with NMO disease severity. J Neuroimmunol 2020;339:577120.
PMID: 31790982